The integrated service offerings of deCODE chemistry and deCODE biostructures provide a unique and comprehensive approach to drug discovery and development outsourcing. deCODE biostructures services span from computer-aided design of expression-optimized synthetic gene constructs to protein expression and ligand bound co-crystal structure determination for purposes of structure based drug design. Capabilities of deCODE chemistry include lead discovery and optimization, development of scalable synthetic routes, custom synthesis of API and intermediates, cGMP production of materials for pre-clinical and clinical studies, and pre-formulation screening. The combined value is that deCODE provides a complete solution for discovering and developing optimized clinical candidates in a time efficient manner. Flexible business terms allow for tailored projects on a fee-for-service basis, or as part of a more substantial collaboration. deCODE’s facilities, located in Woodridge, IL and Bainbridge Island, WA, total over 150,000 sq ft. of multi-disciplinary laboratory space outfitted with state-of-the-art equipment and world-class scientists.
Last Updated: 08-01-2006